Fig. 7From: Systematic proteome-wide Mendelian randomization using the human plasma proteome to identify therapeutic targets for lung adenocarcinomaInteraction between identified plasma proteins and current medication targets for LUAD. LUAD: lung adenocarcinomaBack to article page